{"id":7664,"date":"2025-06-16T10:35:49","date_gmt":"2025-06-16T14:35:49","guid":{"rendered":"https:\/\/web.uri.edu\/pharmce\/?p=7664"},"modified":"2025-06-16T13:13:39","modified_gmt":"2025-06-16T17:13:39","slug":"the-legal-weigh-in-compounded-glp-1ras-and-patient-safety","status":"publish","type":"post","link":"https:\/\/web.uri.edu\/pharmce\/the-legal-weigh-in-compounded-glp-1ras-and-patient-safety\/","title":{"rendered":"The Legal Weigh-In: Compounded GLP-1RAs and Patient Safety"},"content":{"rendered":"\n
\"\"<\/figure>\n\n\n\n

 <\/p>\n\n\n

Overview<\/h1><\/p>\n

Compounded GLP-1ra are very popular and as they continue to be used, the FDA has released several safety alerts regarding their use. The legal landscape for why these products are available and how long they will be available is dependent on pending litigation as well as an FDA determination of a drug shortage. Pharmacists, especially within the primary care setting, need to be aware of the current events surrounding compounded GLP-1ra products from both a legal and safety perspective. The evolving landscape with these compounded products warrants a CE course to ensure pharmacists are kept informed.<\/span> <\/span><\/p>\n

This presentation will explain the legality behind why FDA-approved products can be compounded by groups external to the manufacturer and explain the safety risks that have been identified by FDA safety alerts.<\/span> <\/span><\/p>\n

\n
\n
\"glp\"<\/div>
<\/div>
Click to start course<\/div><\/a><\/div><\/div>\n
\n

CLAIMING CE CREDIT<\/h1>

   <\/p>\n

This educational activity is provided free of charge.<\/h3>\n

If you wish to claim CE credit for participation there is a $7.00 accreditation service fee which is paid when you register for the course.<\/p>\n

<\/p><\/div><\/section><\/p>\n<\/div>\n<\/div>\n

 <\/h3>\n

 <\/p>\n

Target Audience<\/h3>\n

Pharmacists in all practice settings.<\/p>\n

Learning Objectives<\/h3>\n